Hepatitis Monthly

Published by: Kowsar

Association Between Four ABCA1 gene Polymorphisms and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Han Population

Cong Wang 1 , Shousheng Liu 2 , 3 , Linlin Lu 2 , 3 , Songling Liao 1 , Haiyan Yue 1 , Quanjiang Dong 3 , Yongning Xin 1 , 2 , 4 , 5 , * and Shiying Xuan 1 , 2 , 4 , **
Authors Information
1 Department of Gastroenterology, Dalian Medical University, Qingdao266011, China
2 Digestive Disease Key Laboratory of Qingdao, Qingdao 266071, China
3 Central Laboratories, Qingdao Municipal Hospital, Qingdao 266071, China
4 Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao 266011, China
5 Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao 266011, China
Corresponding Authors:
Article information
  • Hepatitis Monthly: June 2018, 18 (6); e66149
  • Published Online: May 22, 2018
  • Article Type: Research Article
  • Received: January 11, 2018
  • Revised: March 24, 2018
  • Accepted: April 1, 2018
  • DOI: 10.5812/hepatmon.66149

To Cite: Wang C, Liu S, Lu L, Liao S, Yue H, et al. Association Between Four ABCA1 gene Polymorphisms and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Han Population, Hepat Mon. 2018 ; 18(6):e66149. doi: 10.5812/hepatmon.66149.

Abstract
Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Liu YL, Reeves HL, Burt AD, Tiniakos D, McPherson S, Leathart JB, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun. 2014;5:4309. doi: 10.1038/ncomms5309. [PubMed: 24978903]. [PubMed Central: PMC4279183].
  • 2. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43(8):617-49. doi: 10.3109/07853890.2010.518623. [PubMed: 21039302].
  • 3. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(4):865-73. doi: 10.1002/hep.21327. [PubMed: 17006923].
  • 4. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis. 2004;8(3):521-33. viii. doi: 10.1016/j.cld.2004.04.004. [PubMed: 15331061].
  • 5. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107(5):450-5. [PubMed: 10569299].
  • 6. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12(5):1106-10. [PubMed: 2227807].
  • 7. Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099-108. doi: 10.1002/hep.27406. [PubMed: 25164003]. [PubMed Central: PMC4867229].
  • 8. Benedict M, Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol. 2017;9(16):715-32. doi: 10.4254/wjh.v9.i16.715. [PubMed: 28652891]. [PubMed Central: PMC5468341].
  • 9. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263-73. doi: 10.1001/jama.2015.5370. [PubMed: 26057287].
  • 10. Wang JT, Liu YL. Non-alcoholic fatty liver disease: the problems we are facing. Hepatobiliary Pancreat Dis Int. 2003;2(3):334-7. [PubMed: 14599934].
  • 11. Musso G, Gambino R, Cassader M. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog Lipid Res. 2013;52(1):175-91. doi: 10.1016/j.plipres.2012.11.002. [PubMed: 23206728].
  • 12. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836-46. doi: 10.1002/hep.24001. [PubMed: 21038418].
  • 13. Sozen E, Ozer NK. Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review. Redox Biol. 2017;12:456-61. doi: 10.1016/j.redox.2017.02.025. [PubMed: 28319895]. [PubMed Central: PMC5357672].
  • 14. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology. 2009;50(6):1827-38. doi: 10.1002/hep.23229. [PubMed: 19937697]. [PubMed Central: PMC5031239].
  • 15. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46(4):1081-90. doi: 10.1002/hep.21763. [PubMed: 17654743].
  • 16. Ioannou GN. The Role of Cholesterol in the Pathogenesis of NASH. Trends Endocrinol Metab. 2016;27(2):84-95. doi: 10.1016/j.tem.2015.11.008. [PubMed: 26703097].
  • 17. Ioannou GN, Morrow OB, Connole ML, Lee SP. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology. 2009;50(1):175-84. doi: 10.1002/hep.22941. [PubMed: 19441103].
  • 18. Caballero F, Fernandez A, De Lacy AM, Fernandez-Checa JC, Caballeria J, Garcia-Ruiz C. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol. 2009;50(4):789-96. doi: 10.1016/j.jhep.2008.12.016. [PubMed: 19231010].
  • 19. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, Hayden MR. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol. 2003;23(8):1322-32. doi: 10.1161/01.ATV.0000078520.89539.77. [PubMed: 12763760].
  • 20. Luciani MF, Denizot F, Savary S, Mattei MG, Chimini G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics. 1994;21(1):150-9. doi: 10.1006/geno.1994.1237. [PubMed: 8088782].
  • 21. Wang S, Smith JD. ABCA1 and nascent HDL biogenesis. Biofactors. 2014;40(6):547-54. doi: 10.1002/biof.1187. [PubMed: 25359426]. [PubMed Central: PMC4294467].
  • 22. Liu Y, Tang C. Regulation of ABCA1 functions by signaling pathways. Biochim Biophys Acta. 2012;1821(3):522-9. doi: 10.1016/j.bbalip.2011.08.015. [PubMed: 21920460]. [PubMed Central: PMC3243790].
  • 23. Hong SH, Rhyne J, Zeller K, Miller M. ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease. Atherosclerosis. 2002;164(2):245-50. [PubMed: 12204794].
  • 24. Tarr PE, Telenti A. Toxicogenetics of antiretroviral therapy: genetic factors that contribute to metabolic complications. Antivir Ther. 2007;12(7):999-1013. [PubMed: 18018758].
  • 25. Rickham PP. Human Experimentation. Code of Ethics of the World Medical Association. Declaration of Helsinki. Br Med J. 1964;2(5402):177. [PubMed: 14150898]. [PubMed Central: PMC1816102].
  • 26. Malhi H, Gores GJ. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28(4):360-9. doi: 10.1055/s-0028-1091980. [PubMed: 18956292]. [PubMed Central: PMC2908270].
  • 27. Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev. 2006;22(6):437-43. doi: 10.1002/dmrr.666. [PubMed: 16832839].
  • 28. Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, Hakkinen AM, et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004;47(8):1360-9. doi: 10.1007/s00125-004-1460-1. [PubMed: 15309287].
  • 29. Manne V, Handa P, Kowdley KV. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clin Liver Dis. 2018;22(1):23-37. doi: 10.1016/j.cld.2017.08.007. [PubMed: 29128059].
  • 30. Kolovou V, Marvaki A, Boutsikou M, Vasilopoulos G, Degiannis D, Marvaki C, et al. Effect of ATP-binding Cassette Transporter A1 (ABCA1) Gene Polymorphisms on Plasma Lipid Variables and Common Demographic Parameters in Greek Nurses. Open Cardiovasc Med J. 2016;10:233-9. doi: 10.2174/1874192401610010233. [PubMed: 27990182]. [PubMed Central: PMC5120382].
  • 31. Abdel-Razek O, Sadananda SN, Li X, Cermakova L, Frohlich J, Brunham LR. Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1. J Clin Lipidol. 2018;12(1):116-21. doi: 10.1016/j.jacl.2017.10.010. [PubMed: 29150341].
  • 32. Gamboa-Melendez MA, Galindo-Gomez C, Juarez-Martinez L, Gomez FE, Diaz-Diaz E, Avila-Arcos MA, et al. Novel association of the R230C variant of the ABCA1 gene with high triglyceride levels and low high-density lipoprotein cholesterol levels in Mexican school-age children with high prevalence of obesity. Arch Med Res. 2015;46(6):495-501. doi: 10.1016/j.arcmed.2015.07.008. [PubMed: 26256050].
  • 33. Min HK, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 2012;15(5):665-74. doi: 10.1016/j.cmet.2012.04.004. [PubMed: 22560219]. [PubMed Central: PMC3361911].
  • 34. Tomita K, Teratani T, Suzuki T, Shimizu M, Sato H, Narimatsu K, et al. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice. Hepatology. 2014;59(1):154-69. doi: 10.1002/hep.26604. [PubMed: 23832448].
  • 35. Wilkens S. Structure and mechanism of ABC transporters. F1000Prime Rep. 2015;7:14. doi: 10.12703/P7-14. [PubMed: 25750732]. [PubMed Central: PMC4338842].
  • 36. Oram JF, Heinecke JW. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev. 2005;85(4):1343-72. doi: 10.1152/physrev.00005.2005. [PubMed: 16183915].
  • 37. Coban N, Onat A, Komurcu Bayrak E, Gulec C, Can G, Erginel Unaltuna N. Gender specific association of ABCA1 gene R219K variant in coronary disease risk through interactions with serum triglyceride elevation in Turkish adults. Anadolu Kardiyol Derg. 2014;14(1):18-25. doi: 10.5152/akd.2013.234. [PubMed: 24084154].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments